GSK (GSK) RNS Announcements

Add to Alert list

Show entries

Filter by source or headline

Date	Time	Source	Announcement
02 Oct 2013	05:04 PM	RNS	Transaction in Own Shares
01 Oct 2013	04:54 PM	RNS	Transaction in Own Shares
01 Oct 2013	04:17 PM	RNS	Director/PDMR Shareholding
01 Oct 2013	12:08 PM	RNS	Total Voting Rights
01 Oct 2013	10:34 AM	RNS	Director/PDMR Shareholding
30 Sep 2013	05:48 PM	RNS	Transaction in Own Shares
30 Sep 2013	05:30 PM	RNS	Share Buy-Back Programme during close period
30 Sep 2013	04:28 PM	RNS	Director/PDMR Shareholding
30 Sep 2013	12:04 PM	RNS	GSK to divest thrombosis brands and related site
27 Sep 2013	05:10 PM	RNS	Transaction in Own Shares
26 Sep 2013	05:38 PM	RNS	Transaction in Own Shares
25 Sep 2013	04:54 PM	RNS	Transaction in Own Shares
24 Sep 2013	05:04 PM	RNS	Transaction in Own Shares
23 Sep 2013	05:30 PM	RNS	Transaction in Own Shares
20 Sep 2013	05:23 PM	RNS	Transaction in Own Shares
20 Sep 2013	05:20 PM	RNS	Director/PDMR Shareholding
19 Sep 2013	06:25 PM	RNS	Relvar Ellipta CHMP Positive Opinion
17 Sep 2013	05:19 PM	RNS	Transaction in Own Shares
16 Sep 2013	05:27 PM	RNS	Director/PDMR Shareholding
16 Sep 2013	05:27 PM	RNS	Transaction in Own Shares
16 Sep 2013	10:00 AM	RNS	dabrafenib/trametinib combo - FDA Priority Review
13 Sep 2013	05:14 PM	RNS	Transaction in Own Shares
12 Sep 2013	05:20 PM	RNS	Transaction in Own Shares
11 Sep 2013	05:23 PM	RNS	Transaction in Own Shares
11 Sep 2013	03:46 PM	RNS	Director/PDMR Shareholding
11 Sep 2013	03:44 PM	RNS	Director/PDMR Shareholding
11 Sep 2013	07:00 AM	RNS	FDA AdCom recommends Anoro Ellipta (UMEC/VI)
09 Sep 2013	08:30 AM	RNS	GSK to divest Lucozade and Ribena for ?1.35bn
05 Sep 2013	07:00 AM	RNS	MAGE A-3 Phase III DERMA Study Results
04 Sep 2013	11:50 AM	RNS	Director/PDMR Shareholding
02 Sep 2013	05:22 PM	RNS	Transaction in Own Shares
02 Sep 2013	12:27 PM	RNS	Total Voting Rights
30 Aug 2013	05:18 PM	RNS	Transaction in Own Shares
29 Aug 2013	05:03 PM	RNS	Transaction in Own Shares
28 Aug 2013	05:08 PM	RNS	Transaction in Own Shares
28 Aug 2013	02:50 PM	RNS	Director/PDMR Shareholding
28 Aug 2013	02:48 PM	RNS	Director/PDMR Shareholding
27 Aug 2013	05:01 PM	RNS	Transaction in Own Shares
23 Aug 2013	04:50 PM	RNS	Transaction in Own Shares
22 Aug 2013	04:51 PM	RNS	Transaction in Own Shares
21 Aug 2013	04:40 PM	RNS	Transaction in Own Shares
20 Aug 2013	04:56 PM	RNS	Transaction in Own Shares
19 Aug 2013	03:58 PM	RNS	Director/PDMR Shareholding
16 Aug 2013	04:50 PM	RNS	Transaction in Own Shares
15 Aug 2013	04:58 PM	RNS	Transaction in Own Shares
14 Aug 2013	04:55 PM	RNS	Transaction in Own Shares
13 Aug 2013	07:00 AM	RNS	Tivicay? (dolutegravir) receives FDA approval
12 Aug 2013	04:55 PM	RNS	Transaction in Own Shares
12 Aug 2013	04:23 PM	RNS	Director/PDMR Shareholding
12 Aug 2013	04:21 PM	RNS	Director/PDMR Shareholding

Showing 2001 to 2050 of 6823 results

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

Friday, 5th July 2024

COMPANIES COVERED:

PSN PIP EML

Election results are dominating the headlines and that big win for Labour is boosting house builders. Elsewhere Pipehawk shares dive off plans to put one operating division into administration whilst Emmerson advances on trading update.

Full Archive

UK 100

Latest directors dealings

6 hours ago UIL Limited (DI)
6 hours ago UIL Limited (DI)
6 hours ago UIL Limited (DI)
6 hours ago UIL Limited (DI)
6 hours ago Schroder UK Mid Cap Fund

All directors dealings today